Roche Drops Patent Claims Over Boniva

Law360, New York (June 30, 2008, 12:00 AM EDT) -- Hoffmann La Roche Inc. has voluntarily dropped its lawsuit that accused two subsidiaries of Actavis Group of infringing a patent protecting popular monthly osteoporosis medication Boniva.

A judge in the U.S. District Court of New Jersey terminated the patent infringement suit on Thursday after the brand pharmaceutical company dropped its claims without prejudice on June 17.

Roche sued Actavis Elizabeth LLC and Actavis Inc. on May 16 after the two companies filed an abbreviated new drug application with the U.S. Food and Drug Administration asking for...
To view the full article, register now.